The Drug Enforcement Administration (DEA) and Virginia Board of Pharmacy (VBP) require that all locations which store Controlled Substances (CS) for use in research must be registered with both the DEA and VBP, and adhere to the other regulations regarding procurement, record keeping, administration (to animals or in vitro), and destruction.
The UVA research community has until February 2018, to fully comply with the crucial state and federal regulations governing the use of Controlled Substances. The UVA Center for Comparative Medicine (CCM) maintains a Wholesale Distributers Registration, and after February 2018, they will only be permitted to dispense Controlled Substances to members of the research community that hold both the required DEA Registration and VBP Registration Certificate.
The Office of the Vice President for Research has produced an instructional manual for the UVA research community which provides guidance in the crucial aspects of the application process, procurement, storage, use and destruction of Controlled Substances.
UVa’s total research funding $338 million, of which $260 million is federal research dollars.